Akebia Therapeutics Inc
F:AX9
Akebia Therapeutics Inc
F:AX9
Price:
0.5994
EUR
6.39%
Market Closed
Market Cap:
€125.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Akebia Therapeutics Inc
F:AX9
|
US |
|
Daiichi Life Group Inc
TSE:8750
|
JP |
|
B
|
BT Wealth Industries PCL
SET:BTW
|
TH |
|
C
|
Club de Polo y Equitacion San Cristobal SA
SGO:POLO
|
CL |
|
Art's Way Manufacturing Co Inc
NASDAQ:ARTW
|
US |
|
St Augustine Gold and Copper Ltd
TSX:SAU
|
SG |
|
G
|
Grupa Pracuj SA
WSE:GPP
|
PL |
|
M
|
MAG Silver Corp
F:MQ8
|
CA |
|
C
|
CrowdStrike Holdings Inc
SWB:45C
|
US |
|
FOS Capital Ltd
ASX:FOS
|
AU |
|
Q
|
QinetiQ Group PLC
XMUN:QY6
|
UK |
|
Ship Healthcare Holdings Inc
F:5EZ
|
JP |
|
Crosswood SA
PAR:CROS
|
FR |
|
APC Minerals Ltd
ASX:APC
|
AU |
|
V
|
ViGenCell Inc
KOSDAQ:308080
|
KR |
|
T
|
Tidewater Renewables Ltd
TSX:LCFS
|
CA |
Multiples-Based Value
The Multiples-Based Value for 
Akebia Therapeutics Inc (AX9) under the Base Case is hidden
EUR.
Compared with the current market price of 0.5994 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AX9 Multiples-Based Value
LOCKED